title: ATM sequences from U2OS cells treated with control (no TALENs)
design: Sequencing from Hubbard et al, 2015.  U2OS cells were nucleofected with a control plasmid. After 48 h, genomic DNA was harvested and the ATM on-target site and its corresponding known off-target sites OffA11 and OffA17 were amplified from this genomic DNA.  The amplified sites were then high-throughput sequenced.  All genomic target sites (ATM on-target, OffA11 and OffA17) are together for this one type of treatment with control plasmid.